Condition: Long COVID

What It Is

Long COVID is the collection of symptoms that persist for months after a SARS-CoV-2 infection, and it is a recognized diagnosis with measurable physical findings behind it. In a Swiss population study that followed more than 1,700 adults, those who had caught COVID carried a clear excess symptom burden over people who were never infected, with the largest gaps in altered taste or smell, post-exertional malaise, breathlessness, reduced concentration and fatigue.

It is one condition that takes several forms, and it affects a minority of the people who catch COVID. Most people improve over the following one to two years, and prevalence has fallen as vaccination spread and later variants proved milder. In that Swiss cohort the share of infected people who had not fully recovered dropped from 22.9% at six months to 17.2% at two years. A minority stay unwell for longer, and that minority deserves to be taken seriously.

The Main Patterns

Long COVID is easier to manage once you know which pattern you have, because the right response differs sharply between them.

Fatigue with post-exertional malaise is the most disabling pattern, and it needs the most care. It is a delayed, disproportionate crash a day or two after physical or mental effort, different from ordinary tiredness. Muscle biopsy work has found physical abnormalities in this group that worsen after the very exercise that triggers a crash. That is a bodily process; it is not deconditioning. Where this pattern is present, the central approach is pacing within an energy limit. A push-through exercise plan can cause a lasting setback.

Breathlessness and dysfunctional breathing is persistent shortness of breath, often with a fast or shallow breathing pattern that outlasts any lung damage. Once the heart and lungs have been checked, it responds to retraining the breath.

Brain fog and cognitive symptoms cover trouble with memory, concentration and word-finding. On formal testing this appears as a measurable deficit, small on average for people who have recovered and larger in those whose symptoms have not resolved.

Dysautonomia and orthostatic intolerance means a racing heart, lightheadedness or fatigue on standing, sometimes diagnosed as postural tachycardia syndrome. It reflects the automatic nervous system not regulating blood pressure and heart rate properly when you stand, and it warrants clinical assessment.

Loss of smell and taste is smell that is absent, reduced or distorted after the infection. It recovers for many people over months, and there is a simple at-home practice that helps.

After severe or hospitalized COVID, people can carry lasting effects across the lungs, heart, muscles and mind at once, alongside the deconditioning of a long admission. Recovery here is slower and needs coordinated support.

What Helps

The best time to act is before infection, not after symptoms begin. Two measures have the best evidence:

• Vaccination before infection. A systematic review of 16 observational studies covering more than 600,000 patients found that being vaccinated before catching COVID was linked to a lower chance of developing long COVID, with the effect pointing the same way in 10 of the 12 studies that examined it. This is observational evidence, not a randomized trial, and people who get vaccinated tend to differ in health, income and healthcare access, the healthy-vaccinee pattern, so some of the gap reflects who chooses vaccination and not the vaccine alone. The signal is real and consistent, and it sits a step below the trial evidence beside it.
• Metformin early in the acute illness. In the COVID-OUT randomized trial, the cheap and widely available diabetes drug metformin, started within days of infection in adults with overweight or obesity, cut the rate of a later long COVID diagnosis from 10.4% to 6.3%.

Both act during the acute infection, so both are a prescriber's decision taken in that window. Neither treats disease that is already established.

For symptoms that are already present, the best results come from matching the treatment to the pattern. Pacing reduces how often and how hard the crashes hit where the crash-after-effort pattern is present. Breathing retraining eased breathlessness on exertion in a randomized trial. Olfactory training, a structured daily sniffing routine, improved measured smell after viral smell loss. For people left with lasting symptoms after a hospital admission, a supervised, individually tailored rehabilitation program that included psychological support improved quality of life, fatigue and mood, with the gains holding at a year.

What Is Oversold

Paxlovid is one of the more heavily promoted ideas, and a longer course did not hold up. In the STOP-PASC randomized trial, a 15-day course of the COVID antiviral did not improve established long COVID symptoms in people who had been ill for well over a year. That result is about treating long-standing disease; it says nothing about antivirals given during the acute infection, which is a separate question.

Other products and services sold for long COVID have not been tested the way vaccination, metformin and the symptom-specific rehabilitation approaches have:

• expensive private treatment courses,
• unvalidated diagnostic tests,
• supplement protocols marketed as cures.

Being told the symptoms are anxiety or simply being out of condition belongs here too, because the muscle, cognitive and cardiovascular findings show a physical process. So does a blanket graded-exercise prescription handed out the same to everyone, which can set back the people who have post-exertional malaise.

Managing The Specific Problem

Care works best when it is built around the pattern you actually have.

Where effort brings on a delayed crash, pace within your energy limit. The dividing line is whether activity reliably triggers a setback a day or two later. If it does, work within your energy envelope, stabilize first, and build very gradually under the guidance of someone familiar with the condition.

Overexertion in this group can cause a lasting deterioration, so pacing comes before any attempt to increase activity.

Where the crash pattern is absent, a gradual, monitored return to gentle activity is reasonable and can rebuild capacity. The judgment is individual, and the plan should stop short of provoking a setback.

For breathlessness, breathing retraining is a low-cost, low-risk first step once a clinician has confirmed the breathlessness is not coming from an untreated heart or lung problem.

For lost or distorted smell, olfactory training is something you can start at home. It means smelling four distinct scents such as rose, lemon, clove and eucalyptus for about 20 seconds each, twice daily, over several months.

For a racing heart or lightheadedness on standing, ask for assessment for postural tachycardia syndrome. Fluids and salt where appropriate, graded position changes and compression can help alongside a clinical review.

For disturbed sleep and low mood, treat them directly. Unrefreshing sleep worsens fatigue, mood and thinking, and both sleep and mood are treatable in their own right. Treating them supports the rest of recovery.

The Research & Studies

Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.

Respiratory Infection

Long COVID is a real condition, and 17.2% were still not fully recovered two years after infectionModerate · mixed

In plain terms

Long COVID is a measurable condition, not something imagined. Compared with people who were never infected, those who caught COVID reported clearly more fatigue, breathlessness, brain fog and loss of smell. Most improve over the following two years, but close to one in six were still not fully recovered at two years.

In detail

Ballouz 2023 (BMJ) followed 1,106 adults in canton Zurich with a confirmed SARS-CoV-2 infection before they were vaccinated, alongside 628 uninfected adults, from six to 24 months after infection. The proportion reporting incomplete recovery fell from 22.9% at six months to 18.5% at 12 months and 17.2% at 24 months. Most participants continued to recover (68.4%) or improved overall (13.5%), while 5.2% worsened, 4.4% had stable (unchanged) health impairment, and 8.5% had alternating periods of recovery and impairment. Adjusted excess risk versus the uninfected at six months was 17.0% overall, with the highest excesses for altered taste or smell, post-exertional malaise, reduced concentration, dyspnea and fatigue.

How to use it

Expect gradual improvement for most people over months to a couple of years, and take the persistence of symptoms in a minority seriously rather than dismissing it. The trajectory varies, so tracking your own symptoms over time is more useful than a single snapshot.

The study · 1

Ballouz 2023, BMJ · BMJ

Metformin early in acute COVID cut long COVID diagnoses from 10.4% to 6.3%Moderate

In plain terms

In people treated soon after catching COVID, the cheap, widely available diabetes drug metformin cut the chance of later being diagnosed with long COVID by about four in every hundred people treated. It is the clearest positive result so far for preventing long COVID with a medication, and it worked best when started in the first few days.

In detail

Bramante 2023 (Lancet Infectious Diseases) reports a prespecified secondary outcome of COVID-OUT, a randomized, quadruple-blind, phase 3 trial in adults aged 30 to 85 with overweight or obesity and COVID-19 symptoms for under seven days. Of 1,126 participants followed (564 metformin, 562 placebo; 56% female), the cumulative incidence of a provider-diagnosed long COVID by day 300 was 6.3% with metformin versus 10.4% with placebo (HR 0.59, 95% CI 0.39 to 0.89; P=0.012), an absolute reduction of 4.1%. When metformin was begun within three days of symptom onset the HR was 0.37 (95% CI 0.15 to 0.95). Ivermectin (HR 0.99) and fluvoxamine (HR 1.36) did not reduce incidence.

How to use it

This is a prevention finding for the acute infection window, not a treatment for established long COVID, and any use of metformin during COVID is a decision for a prescriber. It does not mean supplements marketed for the same purpose work.

The study · 1

Bramante 2023, Lancet Infect Dis (COVID-OUT) · Lancet Infect Dis

Supervised, tailored rehabilitation improved quality of life and fatigue, holding at 12 monthsModerate

In plain terms

For people who had been hospitalized with COVID and were left with lasting symptoms, an eight-week online program combining supervised group exercise and psychological support improved quality of life, fatigue and mood more than usual care, and the gains held at a year. It shows structured, guided rehabilitation can help, when it is matched to the person.

In detail

McGregor 2024 (BMJ) randomized 585 adults (mean age 56, 52% female) discharged from UK hospitals at least three months earlier with ongoing physical or mental-health sequelae to the REGAIN intervention (weekly home-based, live, supervised group exercise plus psychological support over eight weeks) or best-practice usual care (a single advice session). At three months the intervention improved health-related quality of life (adjusted PROMIS-PROPr difference 0.03, 95% CI 0.01 to 0.05; P=0.02), driven by depression (1.39), fatigue (2.50) and pain-interference (1.80) subscores, with benefit maintained to 12 months. Of 21 serious adverse events, one was possibly related to the intervention.

How to use it

Structured rehabilitation helps when it is supervised and tailored, including a psychological-support element, rather than a generic exercise handout. Where the post-exertional crash pattern is present, the program has to be built around pacing.

The study · 1

McGregor 2024, BMJ (REGAIN) · BMJ

A 15-day Paxlovid course did not improve established long COVID symptomsModerate · no effect

In plain terms

A 15-day course of the COVID antiviral Paxlovid did not improve established long COVID symptoms in a randomized trial. It is a useful check on one of the more heavily promoted off-label ideas: the pill that helps the acute infection did not help people already living with the condition.

In detail

Geng 2024 (JAMA Internal Medicine) randomized 155 adults (median age 43, 59% female) with moderate-to-severe post-acute sequelae of at least three months, a mean of 17.5 months after infection, in a 2:1 ratio to 15 days of nirmatrelvir-ritonavir or placebo-ritonavir. The primary outcome, pooled severity across fatigue, brain fog, shortness of breath, body aches, gastrointestinal and cardiovascular symptoms at 10 weeks, showed no significant between-group difference, and there were no significant differences in global-impression scores or PROMIS fatigue, dyspnea, cognitive-function and physical-function measures. Adverse-event rates were similar.

How to use it

This argues against paying for extended antiviral courses to treat long-standing symptoms. It does not rule out benefit from antivirals given during the acute infection, which is a separate question.

The study · 1

Geng 2024, JAMA Intern Med (STOP-PASC) · JAMA Intern Med

Smell training nearly tripled the odds of meaningful smell recovery (odds ratio 2.77)Moderate

In plain terms

For smell lost after a viral infection, deliberately sniffing a set of strong scents twice a day over months, called olfactory training, improved measured smell more than doing nothing. It is cheap, safe, and something a person can do at home, which makes it a sensible first step for post-COVID smell loss.

In detail

Kattar 2021 (Otolaryngology-Head and Neck Surgery) reviewed 16 studies of olfactory training for post-viral olfactory dysfunction and pooled four in meta-analysis. All studies reported clinically significant improvement on Sniffin Sticks testing (a change in TDI score above 5.5), and the pooled odds of achieving a clinically important difference were 2.77 times higher with training than with controls (95% CI 1.67 to 4.58). Protocols varied and the authors noted they may benefit from further standardization.

How to use it

Olfactory training means smelling four distinct scents such as rose, lemon, clove and eucalyptus for about 20 seconds each, twice daily, for several months. It is low-cost and low-risk, so it is reasonable to start while smell is still absent.

The study · 1

Kattar 2021, Otolaryngol Head Neck Surg · Otolaryngol Head Neck Surg

Vaccination before infection was linked to less long COVID in 10 of 12 studiesEmerging

In plain terms

Being vaccinated before catching COVID appears to lower the chance of going on to develop long COVID, with more doses linked to a bigger drop. The studies point the same way, but they are the weaker observational kind, so this points a consistent direction rather than a settled number.

In detail

Byambasuren 2023 (BMJ Medicine) searched to August 2022 and found no randomized trials, so it pooled 16 observational studies of 614,392 patients across five countries. Of 12 studies reporting vaccination before infection, 10 found a significant reduction in long COVID incidence, with odds ratios of 0.22 to 1.03 for one dose, 0.25 to 1 for two doses, and 0.16 for three doses. Five studies of vaccination after infection reported odds ratios of 0.38 to 0.91. High heterogeneity prevented a meta-analysis, and the authors rated the certainty of evidence low because the studies did not adjust for confounders such as other protective behaviors.

How to use it

Vaccination is the best-supported single step for lowering long COVID risk, and it works before infection, so keeping up to date matters most before you are exposed rather than after symptoms start.

The study · 1

Byambasuren 2023, BMJ Med · BMJ Med

A six-week breathing program eased breathlessness on exertion after COVIDEmerging

In plain terms

For people left short of breath after COVID, a six-week online breathing program built around singing techniques eased breathlessness during activity and lifted the mental-wellbeing side of quality of life. It did not change the physical-function score, so it is a helpful support for symptoms rather than a cure.

In detail

Philip 2022 (Lancet Respiratory Medicine) randomized 150 adults with ongoing breathlessness at least four weeks after COVID-19 to the English National Opera Breathe program, a six-week online course focused on breathing retraining through singing, or to usual care. Compared with usual care, the intervention improved the RAND-36 mental-health composite (coefficient 2.42, 95% CI 0.03 to 4.80; P=0.047) and the running breathlessness visual analogue scale (-10.48, 95% CI -17.23 to -3.73; P=0.0026), but not the physical-health composite (0.60; P=0.54) or most other secondary measures. One minor self-limiting adverse event was reported.

How to use it

Breathing retraining is a low-risk, low-cost option worth trying for breathlessness and dysfunctional breathing, alongside, not instead of, a medical check that the breathlessness is not from an untreated heart or lung problem.

The study · 1

Philip 2022, Lancet Respir Med (ENO Breathe) · Lancet Respir Med

Cognition

Brain fog is measurable, a 0.42 SD cognitive deficit where symptoms persistModerate · risk

In plain terms

Brain fog is measurable, not just a feeling. On cognitive testing, people who had recovered from COVID scored slightly lower than those never infected, and people still living with symptoms scored lower again. The gaps are small on average but consistent, and they were larger for people infected earlier in the pandemic.

In detail

Hampshire 2024 (New England Journal of Medicine) invited 800,000 adults in the REACT study in England to an online assessment; 112,964 completed a battery of eight tasks yielding a global cognitive score. Adjusted for confounders, participants whose symptoms resolved in under four weeks or by at least 12 weeks had global deficits of -0.23 SD (95% CI -0.33 to -0.13) and -0.24 SD (95% CI -0.36 to -0.12) versus the no-COVID group, while those with unresolved persistent symptoms had a -0.42 SD deficit (95% CI -0.53 to -0.31). Deficits were larger for the original and B.1.1.7 variants than for later Omicron-era infections.

How to use it

Take cognitive symptoms seriously and mention them to a clinician; for most recovered people the measured effect is small, and earlier-variant infections drove the larger numbers.

The study · 1

Hampshire 2024, N Engl J Med · N Engl J Med

Neuropsychological tests showed a medium-to-large cognitive deficit (Hedges g -0.68)Emerging · risk

In plain terms

Pooling the early studies that used formal neuropsychological tests, people with lingering COVID symptoms performed clearly worse than healthy volunteers. The result lines up with the larger community data, though these were small, varied studies.

In detail

Sobrino-Relano 2023 (Scientific Reports) systematically reviewed 25 studies and meta-analyzed six that compared objective neuropsychological performance, totalling 175 people who had recovered from COVID and 275 healthy controls. A random-effects model gave an overall effect of Hedges g -0.68 (95% CI -1.05 to -0.31; Z=3.58, P<0.001), indicating a medium-to-large deficit, with moderate heterogeneity (I2 63%).

How to use it

Objective testing can confirm and characterize cognitive difficulties when they are affecting work or daily life, which is more useful than reassurance alone for someone who senses their thinking has changed.

The study · 1

Sobrino-Relano 2023, Sci Rep · Sci Rep

Heart And Vascular

Heart, stroke and clot risk stayed raised for months after COVID, even without hospitalizationModerate · risk

In plain terms

In the months after COVID, the risk of heart problems, stroke and blood clots is higher than in people who were not infected, and it is raised even for those who were never hospitalized. This is why new chest pain, severe breathlessness, or signs of a clot after COVID are worth getting checked promptly.

In detail

Xie 2022 (Nature Medicine) used US Department of Veterans Affairs data to compare 153,760 people with COVID-19 against contemporary (5,637,647) and historical (5,859,411) control cohorts, estimating risks and one-year burdens of prespecified incident cardiovascular outcomes beyond 30 days. Risks were increased across cerebrovascular disorders, dysrhythmias, ischemic and non-ischemic heart disease, pericarditis, myocarditis, heart failure and thromboembolic disease, were evident among non-hospitalized individuals, and increased in a graded fashion with the care setting of the acute infection.

Who this may not transfer to:The Veterans Affairs population is overwhelmingly male and older, so the exact risk magnitudes may differ for women and younger adults; other cohorts that included more women have reported raised post-COVID cardiovascular risk in the same direction.

How to use it

After COVID, treat new or worsening chest pain, severe or sudden breathlessness, fainting, or signs of a clot such as a swollen painful calf or coughing blood as reasons to seek care rather than to wait, and keep up routine attention to blood pressure and cholesterol.

The study · 1

Xie 2022, Nat Med · Nat Med

Anxiety And Stress

New anxiety, mood or neurological diagnoses reached 33.6% within six months of COVIDModerate · risk

In plain terms

In the half-year after COVID, new anxiety, mood and, less often, neurological diagnoses were more common than after flu or other chest infections. Distress after long COVID is common and understandable, and it is a reason for support, not a sign the physical symptoms are imagined.

In detail

Taquet 2021 (Lancet Psychiatry) analyzed electronic health records of 236,379 COVID-19 survivors, comparing them with propensity-matched cohorts of influenza and other respiratory-tract-infection patients. The six-month incidence of any of 14 neurological or psychiatric outcomes was 33.6% (12.8% first diagnoses); incidence rose to 46.4% after intensive-care admission. Versus influenza, hazard ratios were 1.44 for any diagnosis and 1.78 for a first diagnosis; versus other respiratory infections, 1.16 and 1.32. Ischemic stroke incidence was 2.10% across the whole cohort and higher after severe illness. Results were robust across sensitivity analyzes.

How to use it

Persistent low mood, anxiety, or any thoughts of self-harm after COVID deserve the same prompt support as the physical symptoms; treating the mood does not mean the rest is in the mind.

The study · 1

Taquet 2021, Lancet Psychiatry · Lancet Psychiatry

Energy And Fatigue

Pacing reduced the frequency and intensity of post-exertional crashesEmerging

In plain terms

For the people whose symptoms flare a day or two after too much activity, the central approach is pacing: staying within an energy limit so you do not trigger a crash. Where this pattern is present, pacing reduced how often and how hard the crashes hit. People who do not have this crash pattern were generally able to build activity gradually under supervision without setbacks.

In detail

Pouliopoulou 2025 (Archives of Physical Medicine and Rehabilitation) pooled observational and interventional studies to February 2025. The prevalence of post-exertional malaise in community-dwelling adults with post-COVID condition was 25% (95% CI 0.17 to 0.36; 10 studies, 4,076 participants; low certainty). Five interventional studies (193 patients) found a decrease in the frequency and intensity of post-exertional malaise after individually tailored rehabilitation centred on pacing. Among studies whose participants did not have prominent post-exertional malaise, seven of eight with a therapeutic-exercise component reported no post-exertional symptom exacerbation from the exercise. All studies carried a high to very high risk of bias.

How to use it

The dividing line is whether effort reliably brings on a delayed crash. If it does, work within your energy envelope and progress by stabilizing first, not by pushing through. If it does not, a gradual, supervised increase in activity is reasonable. Either way, the plan is individual, not the same for everyone.

The study · 1

Pouliopoulou 2025, Arch Phys Med Rehabil · Arch Phys Med Rehabil

Muscle biopsies found physical abnormalities that worsen after post-exertional malaisePreliminary · mixed

In plain terms

When researchers looked inside the muscles of people with long COVID before and after exercise, they found physical changes that got worse after the activity that triggered a crash. This is evidence that post-exertional malaise is a bodily process, not a matter of being out of shape or anxious.

In detail

Appelman 2024 (Nature Communications) was a longitudinal case-control study (NCT05225688) comparing people with long COVID and matched healthy controls, with muscle biopsies and blood taken before and after a maximal exercise test designed to provoke post-exertional malaise. Compared with controls, patients had skeletal-muscle structural changes associated with lower exercise capacity, and after exercise they showed local and systemic metabolic disturbances, severe exercise-induced myopathy, and tissue infiltration of amyloid-containing deposits, several of which worsened following the induction of post-exertional malaise.

How to use it

This helps explain why pushing through effort can set some people back rather than build them up, and it supports approaching activity cautiously where the crash pattern is present.

The study · 1

Appelman 2024, Nat Commun · Nat Commun

The Chinese Medicine View

Chinese medicine has a long tradition of treating the aftermath of a serious febrile illness, which the Warm disease (Wen Bing) school described as a pathogen that lingers and depletes the body after the acute fever passes. It reads long COVID as an aftermath state, and the patterns below are an interpretive lens, not a description of your test results. This is offered as supportive care that sits alongside medical assessment, and a practitioner is the right way to work with it, because a page cannot take your pulse or read your tongue. Chinese medicine would also caution against overtreating a depleted person: strong, draining or overly stimulating approaches can deepen exhaustion, and where effort brings on a crash, the same restraint that Western guidance calls pacing applies here too.

Qi And Yin Deficiency After A Warm Disease

Exhaustion, breathlessness on exertion, a dry mouth, night sweats and a thin rapid pulse, read as the fever having consumed both the energy and the fluids. The direction is to gently tonify Qi and nourish Yin.

Lung And Spleen Deficiency

Weak breath, a soft cough, poor appetite, loose stools and heavy fatigue after eating, read as the Lung and Spleen left weak after the illness. The direction is to strengthen both and rebuild the source of Qi slowly.

Kidney Deficiency

A deeper, constitutional exhaustion with lower back and knee weakness, poor stamina and low drive, read as the deepest reserve being drawn down by a long illness. The direction is to support the Kidney and restore over time.

Lingering Pathogen With Damp-Heat

Low-grade heat, a heavy foggy head, a thick tongue coat and symptoms that flare and settle, read as a residual pathogen that has not fully cleared. The direction is to clear what remains while protecting the depleted body underneath.

Blood Stasis

Fixed aches, chest tightness, palpitations and a dusky tongue, read as circulation that has become stagnant after the illness. The direction is to move Blood gently, a pattern that overlaps with the raised clotting and cardiovascular risk Western medicine tracks after COVID.

Cautions For This Practice

Extra restraint

Everything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.

Pushing through effort risks lasting setbacks, and 58.7% surveyed met the ME/CFS crash threshold

Twomey 2022 (Physical Therapy) was a cross-sectional survey of 213 adults with persistent symptoms after COVID-19, using the Functional Assessment of Chronic Illness Therapy-Fatigue Scale and the DePaul Symptom Questionnaire for post-exertional malaise. Mean fatigue score was 18 (SD 10) on a 0 to 52 scale where lower is worse, with 71.4% experiencing clinically relevant chronic fatigue and 58.7% meeting ME/CFS post-exertional malaise thresholds. The authors advised that post-exertional symptom exacerbation must be monitored and that rehabilitation should be individually designed, beginning with pacing to stabilize symptoms.Twomey 2022, Phys Ther

Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.

When to See Someone

Most of long COVID is managed with time, pacing and support, and improves over months. This is the short list of situations that need a professional. See a doctor, and urgently where noted, if you have:

• New or worsening chest pain, severe or sudden breathlessness, or fainting. The risk of heart problems, stroke and blood clots is raised in the months after COVID, even in people who were not hospitalized, so these need prompt cardiac and clot assessment(seek urgent care)
• Signs of a blood clot such as a swollen, painful or hot calf, or coughing up blood, which need same-day assessment(seek urgent care)
• New neurological symptoms such as face drooping, weakness or numbness on one side, difficulty speaking, or a sudden severe headache, which can point to a stroke(seek urgent care)
• Severe low mood, hopelessness, or any thoughts of harming yourself. Distress after long COVID is common and treatable, and it deserves the same prompt help as the physical symptoms(seek urgent care)
• Symptoms that are severe or getting worse instead of slowly settling, or a new symptom you cannot account for, which warrant review rather than waiting
• A reliable, delayed crash lasting a day or more after even small physical or mental effort (post-exertional malaise). This is a signal to stay within your limits and pace, since exceeding the limit can cause a lasting setback

None of this is meant to alarm you. Long COVID is real, it is manageable, and for most people it improves with time and the right pace. The point of the list is only to catch the few situations that need more than patience and support. Start slow, get the treatable causes checked, and see someone if any of the above fit.

Common Questions

Is long COVID real, or is it anxiety or being out of shape?

It is real and measurable. Compared with people never infected, those who caught COVID report clearly more fatigue, breathlessness, brain fog and lost smell, and the brain fog shows up as a measurable dip on cognitive testing. Muscle biopsies in people with the crash-after-effort pattern found physical abnormalities that worsen after exertion. The evidence points to a bodily process, not a state of mind.

How long does long COVID last?

For most people it improves over the first one to two years. In a Swiss cohort that followed adults infected before vaccination, the proportion who had not fully recovered fell from 22.9% at six months to 17.2% at two years, and most participants either kept recovering or improved overall. A minority stay symptomatic for longer, and tracking your own symptoms over time tells you more than any single snapshot.

Should I exercise, or will it make me worse?

It depends entirely on whether effort brings on a delayed crash. Where that post-exertional pattern is present, a general exercise plan can cause a lasting setback, and pacing within your energy limit is the safer approach. Where the crash pattern is absent, a slow, monitored return to gentle activity is reasonable and can rebuild capacity. The approach to avoid is a blanket graded-exercise prescription applied the same to everyone.

What is post-exertional malaise?

It is a delayed, disproportionate crash that follows physical or mental effort, usually a day or two later, and it can last for days. In one survey of adults with long COVID, 58.7% met the same post-exertional malaise thresholds used in myalgic encephalomyelitis and chronic fatigue syndrome. Muscle biopsy studies show it corresponds to changes that deepen after the exertion that provokes it.

Can anything prevent long COVID?

Yes, and prevention has the strongest evidence of anything here. Vaccination before infection was linked to a lower chance of long COVID across most studies that looked at it. In the COVID-OUT trial, metformin started within days of a COVID infection in adults with overweight or obesity cut later long COVID diagnoses from 10.4% to 6.3%. Both act around the acute infection, which is why keeping up to date before you are exposed matters most.

Does any medication treat established long COVID?

No single drug has been shown to reverse it once it is established. A 15-day course of the antiviral Paxlovid did not improve symptoms in people who had been ill for well over a year. The gains that do exist come from treating the specific problem, through breathing retraining, smell training, sleep and mood support, and supervised rehabilitation matched to the person.

Will my sense of smell come back?

For many people it returns over months. Olfactory training helps: in a pooled analysis of post-viral smell loss, people who trained had 2.77 times the odds of a meaningful improvement compared with those who did not. It is cheap, safe and done at home, so it is a sensible first step while smell is still absent.